HR 3248 United States House · 118th Congress

Diagnostic Lab Testing Transparency Act

This bill requires Medicare-participating clinical diagnostic labs to publicly disclose pricing for covered tests starting January 2025. Labs must post three specific prices online: the discounted cash price, minimum negotiated rate with insurers, and maximum negotiated rate for each test, including related services like specimen collection. The information must be updated annually and made accessible on a public website. This directly affects labs that serve Medicare patients, aiming to increase price transparency for consumers and insurers.
Bill status in committee 1 of 4 stages cleared
Introduction
May 2023
Committee Review
Floor Vote
President
Introduced May 11, 2023 Last action Dec 17, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
4
Key actions
0
Committee
3
Dec 17, 2024
Committee
Referred to the Subcommittee on Health.
lower
May 12, 2023
Committee
Referred to the Subcommittee on Health.
lower
May 11, 2023
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
May 11, 2023
Introduced
Introduced in House
lower
1 primary · 1 co-sponsor

Sponsors